Suppr超能文献

HIV-1 A亚型蛋白酶未结合形式的结构:与其他HIV亚型蛋白酶未结合形式的比较。

Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.

作者信息

Robbins Arthur H, Coman Roxana M, Bracho-Sanchez Edith, Fernandez Marty A, Gilliland C Taylor, Li Mi, Agbandje-McKenna Mavis, Wlodawer Alexander, Dunn Ben M, McKenna Robert

机构信息

Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32610, USA.

出版信息

Acta Crystallogr D Biol Crystallogr. 2010 Mar;66(Pt 3):233-42. doi: 10.1107/S0907444909054298. Epub 2010 Feb 12.

Abstract

The crystal structure of the unbound form of HIV-1 subtype A protease (PR) has been determined to 1.7 A resolution and refined as a homodimer in the hexagonal space group P6(1) to an R(cryst) of 20.5%. The structure is similar in overall shape and fold to the previously determined subtype B, C and F PRs. The major differences lie in the conformation of the flap region. The flaps in the crystal structures of the unbound subtype B and C PRs, which were crystallized in tetragonal space groups, are either semi-open or wide open. In the present structure of subtype A PR the flaps are found in the closed position, a conformation that would be more anticipated in the structure of HIV protease complexed with an inhibitor. The amino-acid differences between the subtypes and their respective crystal space groups are discussed in terms of the differences in the flap conformations.

摘要

已确定HIV-1 A亚型蛋白酶(PR)未结合形式的晶体结构,分辨率达到1.7埃,并在六方空间群P6(1)中作为同二聚体进行了精修,R(cryst)为20.5%。该结构在整体形状和折叠方式上与先前确定的B、C和F亚型PR相似。主要差异在于瓣状区域的构象。在四方空间群中结晶的未结合B和C亚型PR的晶体结构中,瓣状结构要么是半开放的,要么是完全开放的。在目前A亚型PR的结构中,瓣状结构处于闭合位置,这种构象在与抑制剂复合的HIV蛋白酶结构中更易预期。根据瓣状构象的差异,讨论了各亚型之间的氨基酸差异及其各自的晶体空间群。

相似文献

1
Structure of the unbound form of HIV-1 subtype A protease: comparison with unbound forms of proteases from other HIV subtypes.
Acta Crystallogr D Biol Crystallogr. 2010 Mar;66(Pt 3):233-42. doi: 10.1107/S0907444909054298. Epub 2010 Feb 12.
2
High-resolution structure of unbound human immunodeficiency virus 1 subtype C protease: implications of flap dynamics and drug resistance.
Acta Crystallogr D Biol Crystallogr. 2008 Jul;D64(Pt 7):754-63. doi: 10.1107/S090744490801278X. Epub 2008 Jun 18.
3
Structural insights into the South African HIV-1 subtype C protease: impact of hinge region dynamics and flap flexibility in drug resistance.
J Biomol Struct Dyn. 2013 Dec;31(12):1370-80. doi: 10.1080/07391102.2012.736774. Epub 2012 Nov 12.
7
Conformational flexibility in the flap domains of ligand-free HIV protease.
Acta Crystallogr D Biol Crystallogr. 2007 Aug;63(Pt 8):866-75. doi: 10.1107/S0907444907029125. Epub 2007 Jul 17.
8
Contribution of the 80s loop of HIV-1 protease to the multidrug-resistance mechanism: crystallographic study of MDR769 HIV-1 protease variants.
Acta Crystallogr D Biol Crystallogr. 2011 Jun;67(Pt 6):524-32. doi: 10.1107/S0907444911011541. Epub 2011 May 17.
9
Computational analysis of HIV-1 protease protein binding pockets.
J Chem Inf Model. 2010 Oct 25;50(10):1759-71. doi: 10.1021/ci100200u.
10
Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease.
Proteins. 2000 Jan 1;38(1):29-40. doi: 10.1002/(sici)1097-0134(20000101)38:1<29::aid-prot4>3.0.co;2-n.

引用本文的文献

1
Structural Catalytic Core of the Members of the Superfamily of Acid Proteases.
Molecules. 2024 Jul 23;29(15):3451. doi: 10.3390/molecules29153451.
3
The evolution of the HIV-1 protease folding stability.
Virus Evol. 2022 Dec 5;8(2):veac115. doi: 10.1093/ve/veac115. eCollection 2022.
4
Optimizing the refinement of merohedrally twinned P6 HIV-1 protease-inhibitor cocrystal structures.
Acta Crystallogr D Struct Biol. 2020 Mar 1;76(Pt 3):302-310. doi: 10.1107/S2059798320001989. Epub 2020 Mar 2.
5
An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.
J Comput Aided Mol Des. 2018 Mar;32(3):459-471. doi: 10.1007/s10822-018-0099-9. Epub 2018 Feb 3.
8
Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.
Methods Enzymol. 2015;564:153-87. doi: 10.1016/bs.mie.2015.07.019. Epub 2015 Sep 1.
9
Conformational variation of an extreme drug resistant mutant of HIV protease.
J Mol Graph Model. 2015 Nov;62:87-96. doi: 10.1016/j.jmgm.2015.09.006. Epub 2015 Sep 8.
10
Conformation of inhibitor-free HIV-1 protease derived from NMR spectroscopy in a weakly oriented solution.
Chembiochem. 2015 Jan 19;16(2):214-8. doi: 10.1002/cbic.201402585. Epub 2014 Dec 2.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.
Infect Genet Evol. 2010 Apr;10(3):373-9. doi: 10.1016/j.meegid.2009.06.019. Epub 2009 Jul 2.
4
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects.
Antiviral Res. 2009 Aug;83(2):118-26. doi: 10.1016/j.antiviral.2009.04.001. Epub 2009 Apr 9.
5
Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
J Antimicrob Chemother. 2009 Mar;63(3):593-9. doi: 10.1093/jac/dkn526. Epub 2009 Jan 10.
7
HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.
AIDS Res Hum Retroviruses. 2008 Nov;24(11):1449-54. doi: 10.1089/aid.2008.0180.
9
Effectiveness of commercial inhibitors against subtype F HIV-1 protease.
J Enzyme Inhib Med Chem. 2009 Jun;24(3):638-45. doi: 10.1080/14756360802321740.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验